InvestorsHub Logo
Followers 77
Posts 30218
Boards Moderated 85
Alias Born 03/22/2005

Re: None

Thursday, 07/24/2014 7:39:30 PM

Thursday, July 24, 2014 7:39:30 PM

Post# of 72
Organovo and J+J/Janssen Research -

>>> 24-Jul-2014

Regulation FD Disclosure

Item 7.01 Regulation FD Disclosure

On July 24, 2014, Organovo Holdings, Inc. (the "Company") announced that it has entered into an agreement with Janssen Research and Development (JRD), a pharmaceutical company of Johnson & Johnson, to evaluate the use of 3D bio-printed tissue in a drug discovery setting, outside of the Company's work in 3D liver tissue for toxicity testing. Terms have not been disclosed.


Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.